Search Results - "Hunt, KK"

Abstract P6-12-02: isomiR-140-3p-regulated mevalonic acid pathway as a potiental target for prevention of triple negative breast cancer by Bhardwaj, A, Singh, H, Trinidad, CM, Albarracin, C, Hunt, KK, Bedrosian, I

“…Abstract Background: Prevention of triple negative breast cancer (TNBC) is hampered by lack of knowledge about the drivers of tumorigenesis. Methods: In order…”
Get full text

Abstract P4-15-10: Second breast events after DCIS: Where, what and when? by King, LM, Yi, M, Krishnamurthy, S, Hunt, KK, Thompson, AM

“…Abstract Background: Detection and diagnosis of ductal carcinoma in situ has substantially increased since the widespread use of mammographic screening with…”
Get full text

Abstract P1-08-13: A prospective evaluation of HLA expression in breast implant associated anaplastic large cell lymphoma to identify disease susceptibility by Tevis, SE, Hunt, KK, Miranda, RN, Butler, CE, Clemens, MW

“…Abstract Background: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma found to occur in association with breast…”
Get full text

Abstract P5-04-03: Palbociclib synergizes with autophagy inhibitors to induce senescence in breast cancer by Keyomarsi, K, Vijayaraghavan, S, Karakas, C, Doostan, I, Chen, X, Bui, T, Hunt, KK, Tripahty, D

“…Abstract This abstract was withdrawn by the authors…”
Get full text

Abstract P6-09-01: Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance) by Boughey, JC, Ballman, KV, McCall, LM, Mittendorf, EA, Hunt, KK

“…Abstract Background: Locoregional recurrence (LRR) is a concern after neoadjuvant chemotherapy. Absolute risk of LRR and risk factors associated with LRR among…”
Get full text

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer by BUZDAR, Aman U, IBRAHIM, Nuhad K, CRISTOFANILLI, Massimo, FRYE, Debra K, SMITH, Terry L, HUNT, Kelly K, SINGLETARY, Sonja E, SAHIN, Aysegul A, EWER, Michael S, BUCHHOLZ, Thomas A, BERRY, Donald, FORTOBAGYI, Gabriel N, FRANCIS, Deborah, BOOSER, Daniel J, THOMAS, Eva S, THERIAULT, Richard L, PUSZTAI, Lajos, GREEN, Marjorie C, ARUN, Banu K, GIORDANO, Sharan H

“…The objective of this study was to determine whether the addition of trastuzumab to chemotherapy in the neoadjuvant setting could increase pathologic complete…”
Get full text

Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial by Wilke, Lee Gravatt, McCall, Linda M, Posther, Katherine E, Whitworth, Pat W, Reintgen, Douglas S, Leitch, A Marilyn, Gabram, Sheryl G A, Lucci, Anthony, Cox, Charles E, Hunt, Kelly K, Herndon, 2nd, James E, Giuliano, Armando E

“…American College of Surgeons Oncology Group Z0010 is a prospective multicenter trial designed to evaluate the prognostic significance of micrometastases in the…”
Get full text

Abstract P6-09-17: Evaluation of a risk score based on biologic factors to enhance prognostic stratification by the American Joint Committee on Cancer (AJCC) Staging System by Mittendorf, EA, Vila, J, Yi, M, Chavez-MacGregor, M, Chen, RL, Giordano, SH, Hunt, KK

“…Abstract Background: The 7th edition AJCC staging system provides prognostic information based on the anatomic extent of disease determined by the tumor size…”
Get full text

Abstract P5-08-02: Improving the AJCC breast cancer staging system by incorporating tumor biomarkers by Chavez-MacGregor, M, Mittendorf, EA, Clarke, CA, Lichensztajn, DY, Hunt, KK, Giordano, SH

“…Abstract BACKGROUND: The current American Joint Committee on Cancer (AJCC) breast cancer staging system provides important prognostic information, however its…”
Get full text

Surgeon perception versus reality: Opioid use after breast cancer surgery by Park, Ko Un, Kyrish, Kristin, Terrell, John, Yi, Min, Caudle, Abigail S., Hunt, Kelly K., Kuerer, Henry M., Bedrosian, Isabelle, Thompson, Alastair, DeSnyder, Sarah M.

“…Background Few guidelines exist for an opioid prescription after breast surgical oncology (BSO) procedures. We sought to characterize opioid prescribing and…”
Get full text

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks by GREEN, Marjorie C, BUZDAR, Aman U, THERIAULT, Richard L, CARTER, Cynthia, FRYE, Debra, HUNT, Kelly K, SYMMANS, W. Fraser, STROM, Eric A, SAHIN, Aysegul A, SIKOV, William, HORTOBAGYI, Gabriel N, SMITH, Terry, IBRAHIM, Nuhad K, VALERO, Vicente, ROSALES, Marguerite F, CRISTOFANILLI, Massimo, BOOSER, Daniel J, PUSZTAI, Lajos, RIVERA, Edgardo

“…To determine the impact a change in schedule of paclitaxel administration from once every 3 weeks to frequent administration would have on the pathologic…”
Get full text

Abstract OT2-02-03: Magnetic nano-device for identification of the breast sentinel nodes – A novel method by Beitsch, PD, Hunt, KK, Bold, RJ, Gittleman, MA, Blair, SL, Alvarado, MD, Harmer, QJ

“…Abstract Breast sentinel node biopsy (SNB) is a well-established procedure that has supplanted traditional axillary dissection for most clinically…”
Get full text

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor by Babiera, Gildy V, Rao, Roshni, Feng, Lei, Meric-Bernstam, Funda, Kuerer, Henry M, Singletary, S Eva, Hunt, Kelly K, Ross, Merrick I, Gwyn, Karin M, Feig, Barry W, Ames, Frederick C, Hortobagyi, Gabriel N

“…Currently, therapy for breast cancer patients with stage IV disease and an intact primary tumor is metastasis directed; the primary tumor is treated only when…”
Get full text

Abstract P4-20-05: Patient-reported cosmetic outcomes in older breast cancer survivors: A population-based survey study by Swanick, CW, Lei, X, Xu, Y, Shen, Y, Goodwin, NA, Giordano, SH, Hunt, KK, Jagsi, R, Shaitelman, S, Peterson, SK, Smith, BD

“…Abstract Background: For older women with breast cancer, local therapy options may include (1) lumpectomy followed by whole breast irradiation (Lump+WBI), (2)…”
Get full text

Multidisciplinary Intra-Operative Assessment of Breast Specimens Reduces Number of Positive Margins by Tevis, SE, Neuman, HB, Mittendorf, EA, Kuerer, HM, Bedrosian, I, DeSnyder, SM, Thompson, AM, Black, DM, Scoggins, ME, Sahin, AA, Hunt, KK, Caudle, AS

Get full text

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy by CHAGPAR, Anees B, MIDDLETON, Lavinia P, KUERER, Henry M, MERIC-BERNSTAM, Funda, ROSS, Merrick I, SINGLETARY, S. Eva, SAHIN, Aysegul A, DEMPSEY, Peter, BUZDAR, Aman U, MIRZA, Attiqa N, AMES, Fredrick C, BABIERA, Gildy V, FEIG, Barry W, HUNT, Kelly K

“…To assess the accuracy of physical examination, ultrasonography, and mammography in predicting residual size of breast tumors following neoadjuvant…”
Get full text

Delayed-immediate breast reconstruction by KRONOWITZ, Steven J, HUNT, Kelly K, KUERER, Henry M, BABIERA, Gildy, MCNEESE, Marsha D, BUCHHOLZ, Thomas A, STROM, Eric A, ROBB, Geoffrey L

“…In patients with early-stage breast cancer who are scheduled to undergo mastectomy and desire breast reconstruction, the optimal timing of reconstruction…”
Get full text

Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma by Pawlik, Timothy M, Pisters, Peter W T, Mikula, Lynn, Feig, Barry W, Hunt, Kelly K, Cormier, Janice N, Ballo, Matthew T, Catton, Charles N, Jones, Julia J, O'Sullivan, Brian, Pollock, Raphael E, Swallow, Carol J

“…The reported data on surgery plus radiotherapy for retroperitoneal soft tissue sarcomas (RPS) have been mostly from retrospective studies. We evaluated the…”
Get full text

Abstract P2-11-02: Three-year outcomes with hypofractionated (HF) versus conventionally fractionated (CF) whole breast irradiation (WBI) by Shaitelman, SF, Lei, X, Thompson, A, Schlembach, P, Arzu, I, Bloom, ES, Buchholz, DJ, Chronowski, GM, Dvorak, T, Grade, EJ, Hoffman, KE, Kelly, P, Perkins, GH, Reed, V, Shah, S, Stauder, MC, Strom, EA, Tereffe, W, Woodward, WA, Baumann, D, Amaya, D, Guerra, W, Morrison, M, Hortobagyi, G, Hunt, KK, Buchholz, TA, Smith, BD

“…Abstract Background: Adoption of HF-WBI remains low due in part to concerns regarding its safety when used with a tumor bed boost or in patients who have…”
Get full text

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors by CHEN, Lei L, TRENT, Jonathan C, POLLOCK, Raphael E, FEIG, Barry W, HAYES, Kimberly J, CHOI, Haesun, MACAPINLAC, Homer A, HITTELMAN, Walter, VELASCO, Marco A, PATEL, Shreyaskumar, BURGESS, Michael A, BENJAMIN, Robert S, WU, Elsie F, FRAZIER, Marsha L, FULLER, Gregory N, RAMDAS, Latha, WEI ZHANG, RAYMOND, Austin K, PRIETO, Victor G, OYEDEJI, Caroline O, HUNT, Kelly K

“…KIT gain of function mutations play an important role in the pathogenesis of gastrointestinal stromal tumors (GISTs). Imatinib is a selective tyrosine kinase…”
Get full text